TPG Life Sciences Innovations Access Offshore LP — Form D/A
TPG Life Sciences Innovations Access Offshore LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2023-09-08. $9.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-09-08
- Form: D/A
- Accession: 0001874982-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $9.0M
- Investors: 8
- Date of first sale: 2022-09-05
- Security types: fund interests
- SEC file number: 021-458714
Issuer
- Name: TPG Life Sciences Innovations Access Offshore LP
- CIK: 0001945874
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: 200 WEST STREET, NEW YORK, NY, 10017
- Phone: 212-902-1000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ashish Dodia | Executive Officer | Wilmington, DE |
| Jody Flaws | Executive Officer | Austin, TX |
| Richard Ruffer | Executive Officer | Far Hills, NJ |
| NA TPG Life Sciences Innovations Access Advisors LLC | Executive Officer | New York, NY |
Other filings by this issuer (1)
More